What is the equity of Lupin this year?
Lupin has equity of 142.9 B INR this year.
Lupin Equity 2025
Lupin Equity
142.9 B INR
Ticker
LUPIN.NS
ISIN
INE326A01037
In 2025, Lupin's equity was 142.9 B INR, a 14.65% increase from the 124.65 B INR equity in the previous year.
Lupin Aktienanalyse
What does Lupin do?
Lupin Limited is an Indian pharmaceutical company specializing in generics and novel therapies. It was founded in 1968 by Dr. Desh Bandhu Gupta and has experienced rapid growth, becoming one of the leading companies in the global pharmaceutical market. The company's business model involves manufacturing and marketing generics and novel therapies for the treatment of various diseases such as cancer, diabetes, cardiovascular diseases, and respiratory diseases. Lupin operates worldwide with a wide range of partners to distribute its products in over 100 countries. The company is involved in various divisions including generics, novel therapies, biosimilars, and inhalation products. Lupin's generics division encompasses a wide range of products such as antibiotics, antidepressants, antihypertensives, and many other categories. Its novel therapies include innovative products for the treatment of diabetes, cancer, multiple sclerosis, and other chronic diseases. Lupin is also involved in the development of biosimilars, which are imitation biopharmaceuticals manufactured using living organisms. Lastly, the company offers inhalation products for the treatment of respiratory diseases such as asthma and COPD. Lupin has built an impressive product pipeline over the years, having submitted over 174 ANDA applications (for the approval of new generics) to the US FDA and introduced more than 80 new products in the Indian market. It has also established an innovative research and development center that focuses on the discovery of new molecules and the development of new therapeutic approaches. Another important feature of Lupin is its commitment to quality and sustainability. The company has received numerous awards for its product quality and environmental initiatives. In 2019, Lupin received the Sustainable Business Award from CNBC TV18. Overall, Lupin Limited is a successful and fast-growing company specializing in generics and novel therapies. It has a wide range of products and an impressive pipeline, and operates globally. Due to its commitment to quality and sustainability, Lupin Limited has also built a strong reputation among its customers and partners. Lupin ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Lupin's Equity
Lupin's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Lupin's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Lupin's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Lupin's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Lupin’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Lupin stock
What was the equity of Lupin compared to the previous year?
The equity of Lupin has increased/decreased by 14.65% increased compared to the previous year.
What impact does a high equity have on investors of Lupin?
A high equity is advantageous for investors of Lupin as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Lupin?
A low equity can be a risk for investors of Lupin, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Lupin affect the company?
An increase in equity of Lupin can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Lupin affect the company?
A reduction in equity of Lupin can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Lupin?
Some factors that can affect the equity of Lupin include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Lupin so important for investors?
The equity of Lupin is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Lupin take to change the equity?
To change equity, Lupin can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Lupin pay?
Over the past 12 months, Lupin paid a dividend of 8 INR . This corresponds to a dividend yield of about 0.36 %. For the coming 12 months, Lupin is expected to pay a dividend of 7.42 INR.
What is the dividend yield of Lupin?
The current dividend yield of Lupin is 0.36 %.
When does Lupin pay dividends?
Lupin pays a quarterly dividend. This is distributed in the months of August, August, August, August.
How secure is the dividend of Lupin?
Lupin paid dividends every year for the past 23 years.
What is the dividend of Lupin?
For the upcoming 12 months, dividends amounting to 7.42 INR are expected. This corresponds to a dividend yield of 0.34 %.
In which sector is Lupin located?
Lupin is assigned to the 'Health' sector.
Wann musste ich die Aktien von Lupin kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Lupin from 9/1/2024 amounting to 8 INR, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.
When did Lupin pay the last dividend?
The last dividend was paid out on 9/1/2024.
What was the dividend of Lupin in the year 2024?
In the year 2024, Lupin distributed 4 INR as dividends.
In which currency does Lupin pay out the dividend?
The dividends of Lupin are distributed in INR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Lupin
Our stock analysis for Lupin Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lupin Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.